Medicine, climate or space exploration? The main scientific challen...
13 FEBRUARY 2022
Research on Covid-19
Medical research on the SARS-CoV-2 virus, and especially on Omicron (B.1.1.529), the variant of the Coronavirus first identified at the end of November 2021, continues. Research is also constantly monitoring new Covid variants and the long-term effects on people who have recovered from infection.
Alongside the Covid research, the vaccination campaign and research into the origin of the virus will continue. Wealthy countries have started administering booster doses, but unfortunately almost half of the world’s population has not yet received even a single dose of vaccine. To close this huge global gap, we will have to wait for vaccine prices to fall or for pharmaceutical companies to surrender their patents, thus favouring vaccination coverage for poorer countries.
Updated vaccines
2022 could see the development of new messenger RNA vaccines targeting specific Covid variants. Protein-based vaccines are the most conventional type of immunisation (they have been used for decades against several diseases, including hepatitis and shingles) and have shown promising results in phase III COVID-19 clinical trials in 2021. DNA-based vaccines are cheaper to produce than mRNA vaccines and do not require cold storage, so they could be a good alternative for lower-income countries. Other diseases will be targeted: advances are expected in vaccines for HIV (human immunodeficiency virus), malaria (infection caused by protozoan parasites of the genus Plasmodium) and Lyme disease (bacterial infection transmitted by ticks).
The ‘new physics’
Large Hadron Collider (LHC)

Large Hadron Collider (LHC)
Moon missions

Missioni lunari
Moon missions

Missioni lunari
Mars

Marte
Mars

Marte
Climate action
Climate action
Biodiversity
Another key issue in 2022 will be safeguarding biodiversity, working on new targets to slow the massive loss of biological diversity linked to human activities. In the decade 2010-2020, the Aichi Targets (points and strategies, set in 2010, to be achieved by 2020 at global level) were mostly missed: the next UN Convention on Biological Diversity will have to address the situation with new action plans. The Convention is scheduled to meet in Kunming (China) in May 2022, provided that the global health situation does not interfere with the planned programmes.
by Benedetta Palazzo
Biodiversity
Another key issue in 2022 will be safeguarding biodiversity, working on new targets to slow the massive loss of biological diversity linked to human activities. In the decade 2010-2020, the Aichi Targets (points and strategies, set in 2010, to be achieved by 2020 at global level) were mostly missed: the next UN Convention on Biological Diversity will have to address the situation with new action plans. The Convention is scheduled to meet in Kunming (China) in May 2022, provided that the global health situation does not interfere with the planned programmes.
by Benedetta Palazzo
